MAR 13, 2019 02:00 PM PDT

Clinical Updates: Basal Ganglia-Cortical Loop Function During Speech

Presented At Neuroscience 2019
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Associate Professor, Director, Adult Epilepsy & Movement Disorders Surgery, Director, Brain Modulation Laboratory, Faculty Member, University of Pittsburgh Brain Institute, Univ of Pittsburgh
    Biography
      Dr. Richardson is a neurosurgeon-neuroscientist who has directed the Epilepsy and Movement Disorders Surgery Program at the University of Pittsburgh Medical Center (UPMC) since 2011. He received his MD/PhD at Virginia Commonwealth University and completed his neurosurgery residency and postdoctoral research at the University of California San Francisco. At UPMC, he has pioneered the neurosurgical use of interventional-MRI, robotics, gene therapy and closed-loop brain stimulation. Dr. Richardson also founded the Brain Modulation Lab, which conducts human systems neuroscience research using intracranial recording and stimulation, including BRAIN Initiative-funded projects focused on cortical-subcortical interactions during speech and on computational methods for closed-loop brain stimulation.

    Abstract:

    Actions are not mediated solely by cortical processes but rely on communication within basal ganglia-thalamocortical loops. Speech is one example, although how the basal ganglia participate in this uniquely human behavior is not clear. Recognizing that deep brain stimulation (DBS) surgery offers the only opportunity to directly measure neural activity in the human basal ganglia, we initiated studies to understand how speech information is encoded within the subthalamic nucleus (STN)-sensorimotor cortical network. Our team works with patients undergoing deep brain stimulation for movement disorders like Parkinson's disease and essential tremor. We established a novel experimental paradigm, where electrocorticography (ECoG) is recorded simultaneously with STN single unit activity and local field potentials (LFP), during DBS surgery in which patients are awake and speaking. We discovered that STN neuron activity is dynamic during speech production, exhibiting behaviorally-selective inhibition and excitation of separate populations of neurons. At the population level, we found that STN activity tracks with specific articulatory motor features and with gain adjustment in articulatory movements. In addition, our data suggest a role for the STN in speech planning, in that STN activity appears to be modulated prior to speech onset. The goal of this work is to build a neurobiological framework that allows the development of interventions to treat speech disorders involving the basal ganglia.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    AUG 13, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 13, 2019 09:00 AM PDT
    DATE: August 13, 2019TIME: 9:00am PT, 12:00pm ET, 5:00pm BST Molecular complexes are major constituents of cells, hence unraveling their mechanisms is key to fuller comprehension of c...
    NOV 18, 2019 07:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    Loading Comments...
    Show Resources